Bioequivalence Study of Risperidone 1 mg Orally-disintegrating Tablets Under Fasting Conditions
- First Posted Date
- 2010-10-18
- Last Posted Date
- 2010-10-18
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 44
- Registration Number
- NCT01222975
- Locations
- 🇺🇸
aaiPharma Inc., Chapel Hill, North Carolina, United States
A Relative Bioavailability Study of Valacyclovir Hydrochloride Tablets 1gm Under Fed Condition
- First Posted Date
- 2010-10-18
- Last Posted Date
- 2010-10-18
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 40
- Registration Number
- NCT01222897
- Locations
- 🇮🇳
Ranbaxy Clinical Pharmacology Unit, Ranbaxy Laboratories Limited, Noida, Uttar Pradesh, India
A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fasting Condition
- First Posted Date
- 2010-03-02
- Last Posted Date
- 2010-03-02
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 32
- Registration Number
- NCT01079065
- Locations
- 🇮🇳
Ranbaxy Clinical Pharmacology Unit, Ranbaxy Laboratories Limited, Noida, Uttar Pradesh, India
A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fed Condition
- First Posted Date
- 2010-03-02
- Last Posted Date
- 2010-03-02
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 24
- Registration Number
- NCT01079052
- Locations
- 🇮🇳
Ranbaxy Clinical Pharmacology Unit, Ranbaxy Laboratories Limited, Noida, Uttar Pradesh, India
A Relative Bioavailability Study of Acetaminophen 650 mg Extended Release Gelcaps Under Fed Condition
- First Posted Date
- 2010-03-02
- Last Posted Date
- 2010-03-02
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 26
- Registration Number
- NCT01079078
- Locations
- 🇮🇳
Clinical Pharmacology Unit, Majeedia Hospital (2nd Floor), New Delhi, India
A Relative Bioavailability Study of Acetaminophen 650 mg Extended Release Gelcaps Under Fasting Condition
- First Posted Date
- 2010-02-23
- Last Posted Date
- 2010-02-23
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 40
- Registration Number
- NCT01073709
- Locations
- 🇮🇳
Clinical Pharmacology Unit, Majeedia Hospital (2nd Floor), New Delhi, India
Bioequivalence Study of Oxcarbazepine Oral Suspension 300 mg/5 mL Under Fasting Conditions
- First Posted Date
- 2009-08-04
- Last Posted Date
- 2009-08-04
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 40
- Registration Number
- NCT00951600
- Locations
- 🇮🇳
Ranbaxy Clinical Pharmacology Unit, Ranbaxy Laboratories Limited, Noida, Uttar Pradesh, India
Bioequivalence Study of Oxcarbazepine Oral Suspension 300 mg/5mL Under Fed Condition
- Conditions
- Interventions
- First Posted Date
- 2009-08-04
- Last Posted Date
- 2009-08-04
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 40
- Registration Number
- NCT00951847
- Locations
- 🇮🇳
Ranbaxy Clinical Pharmacology Unit, Ranbaxy Laboratories Limited, Noida, Uttar Pradesh, India
Bioequivalence Study of Topiramate Tablets 25mg Under Fed Conditions
- First Posted Date
- 2009-05-15
- Last Posted Date
- 2009-05-15
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 18
- Registration Number
- NCT00902473
- Locations
- 🇨🇦
MDS Pharina Services (Clinical Research Center), Quebec, Canada
Bioequivalence Study of Topiramate Tablets 25mg Under Fasting Conditions
- First Posted Date
- 2009-05-14
- Last Posted Date
- 2009-06-18
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 28
- Registration Number
- NCT00901784
- Locations
- 🇨🇦
MDS Pharina Services (Clinical Research Center), St. Laurent, Québec, Canada